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CYCLOSPORINE (CyA) has contributed 
significantly to the improved success of 
heart, liver, and kidney transplantation. Sev-
eral factors such as disease state, coadminis-
tered drugs, and time elapsed since the trans-
plant surgery influence the dosing regimen of 
Cy A.I During the immediate postoperative 
time period therapeutic blood CyA concentra-
tions can be achieved with doses of 15 to 20 
mg/kg/d, whereas several months after trans-
plantation doses of 3 to 5 mg/kg/d result in 
similar blood Cy A concentrations.2•3 The over-
all goal of our study was to determine the 
factors responsible for the decreased dosage 
requirement of CyA with time. The specific 
objective of this experiment was to determine 
the effect of chronic pretreatment with olive 
oil or CyA on the pharmacokinetics of CyA 
after single-dose oral administration. 
MATERIALS AND METHODS 
Four male beagle dogs weighing between 12 and 15 kg 
were used in this study. The animals received oral CyA 
(300 mg) on three separate occasions after an overnight 
fast. Initially, the dogs received CyA without any pre-
treatment (control period). On the next occasion CyA was 
administered to the same group of dogs after chronic (ten 
days) oral treatment with 3 mL olive oil per day. On the 
last occasion, Cy A was administered a day after chronic 
(ten days) treatment with 300 mg oral CyA per day. 
During each study day, multiple blood samples were 
drawn just before and at various times after CyA admin-
istration and analyzed for unchanged CyA by a high-
pressure liquid chromatographic method.' 
The terminal disposition rate constant (A,) was calcu-
lated by linear regression analysis of the log terminal 
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blood concentration-v-~ime data. The area under 
blood concentratlon-v-tlme curve (AUC) was 
by the trapezoidal method. The principal of 
superposition was used to calculate the actual AUC 
CyA administration in the CyA pretreatment ph 
analysis of variance was used to determine the . 
cance of any differences in the parameters calculated 
P value of <.05 was consider to be significant. . 
RESULTS 
The mean (±SD) peak blood CyA Concen-
tration (cmu ) in the control period was 1,416 
(±364) ng/mL (Table I). The mean c 
values of CyA observed after olive oil trea~ 
ment and after CyA treatment were not sig •. 
nificantly different from the control values. 
There were also no significant differences in 
the time to achieve peak blood concentrations 
(tma.) during the three study periods (Table 
2). 
The mean (±SD) Az of CyA was 0.0839/h 
(± 0.0002), which corresponded to a harmonic 
mean half-life of 8.3 hours during the first 
phase. The half-life was significantly (P < 
.05) prolonged to 14.8 and 22 hours after olive 
oil or CyA treatment, respectively (Table 3). 
The mean (±SD) AUC was 10,166 
(±2,857) ng/mL/h during the control period. 
The mean AUC after olive oil pretreatment 
(17,498 ng/ml/h) and after CyA pretreat-
ment (13,048 ng/ml/h) was significantly 
Table 1. Peak CyA Blood Concentrations 
After Various Pretreatments 
Blood Concentration (ng!mL) 
OIi.eOil Cyclosperine 
Dog No. Control Pretreatment Pretreatment 
1.244 1,072 1,629 
2 1.763 1,337 1.599 
3 1,668 1,204 1,927 
4 987 1.388 1,480 
Mean 1,416 1,250 1,659 
±SD ±364 ±141 ±190 
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rable 2. Time to Achieve Peak CyA 
Blood Concentrations 
Time (hi 
..--------------
Olive Oil Cyclosporine 
Treatment Treatment 
1.4 1.4 
1.1 1.5 
2.3 1.5 
1.6 1.5 
Control 
1)01 /11O. 
~ 1.5 
2 1.6 
1.0 3 
1.1 
1.6 1.5 
±O.5 ±o.o 
....." 1.3 
SO ±0.3 I~---------------------------
(' <: .05) higher than the AUC after the 
control period. 
DISCUSSION 
In the present study we have documented 
tJutt chronic administration of olive oil or 
chronic treatment with CyA results in higher 
blood eyA concentrations in dogs receiving a 
lingle oral dose of CyA as compared with a 
control period. Higher blood CyA concentra-
tion may be the result of alterations in CyA 
absorption, distribution, or metabolism. 
Olive oil increases the oral absorption of 
heparin in rats by increasing bile production 
or by inducing changes in the permeability of 
intestinal microcirculation.6 A similar phe-
nomenon may result in increased CyA absorp-
tion and therefore increased CyA AUC after 
olive oil or CyA pretreatments. However, the 
lack of significant differences in the Cm•x and 
tma. tends to suggest minimal or no change in 
163 
Table 3. CyA Half-Ufe After Various Pretreatments 
Half-life (hi 
Olive Oil Cyclosporine 
Dog No. Control Pretreatment Pretreatment 
1 8.2 14.9 20.5 
2 8.4 12.8 21.5 
3 8.3 16.9 24.8 
4 8.1 15.2 21.8 
Harmonic mean 8.3 14.8 22.0 
the absorption of CyA after pretreatments. 
These results are contrary to the previous 
observations made in kidney transplant 
patients.7 
On the other hand, we observed a signifi-
cant increase in CyA half-life after olive oil or 
CyA pretreatment. Both olive oil and CyA 
may therefore alter CyA disposition. In vitro 
studies using rat liver homogenates indicate 
that CyA is a potent inhibitor of drug metabo-
lism.s In vivo studies in rabbits have demon-
strated impairment in N-demethylation of 
aminopyrine after chronic Cy A treatment.9 
Therefore, changes in the disposition of Cy A 
after chronic olive oil or CyA administration 
appear to be primarily responsible for the 
observed results. However, intravenous and 
oral CyA pharmacokinetic studies in dogs 
after chronic CyA administration are neces-
sary to determine the exact mechanism 
responsible for the altered CyA pharmaco-
kinetics. 
REFERENCES 
I. Ptachcinski RJ, Venkataramanan R, Burckart GJ: 
Clin Pharmacokinet 11: 107, 1986 
2. Griffith BP, Hardesty RL, Trento A, et al: J Thorac 
Cardiovasc Surg 88:952, 1984 
3. Novick AC, Ho-Hsieh H, Steinmuller D, et al: 
Transplantation 42: 154, 1986 
4. Ptachcinski RJ, VenkataramananR. Rosenthal JT, 
el al: Clin Pharmacol Ther 38:296, 1985 
5. Guarini S, Ferrari W:. Pharmacol Res Commun 
17:685, 1985 
6. Bauer LA, Gibaldi M: J Pharmacol Sci 72:978, 
1983 
7. Kahan BD, Ried M, Newburger J: Transplant Proc 
15:446, 1983 
8. Augustine JA, Zemaitis MA: Drug Metab Dispos 
14:73,1986 
9. D'Souza MJ: Effect of immunosuppressants, cydo-
sporine and prednisone, on drug disposition. Doctoral 
dissertation submitted to the University of Pittsburgh, 
1987 
